HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.

Abstract
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in solid tumors. We report the novel benzimidazole analogue AC1-004, obtained from a chemical library using an HRE-dependent cell-based assay in colorectal carcinoma HCT-116 cells. The accumulation of hypoxia-induced HIF-1alpha was inhibited by compound AC1-004 in various cancer cells, including HCT-116, MDA-MB435, SK-HEP1, and Caki-1. Further, AC1-004 down-regulated VEGF and EPO, target genes of HIF-1, and inhibited in vitro tube formation of HUVEC, suggesting its potential inhibitory activity on angiogenesis. Importantly, AC1-004 was found to regulate the stability of HIF-1alpha through the Hsp90-Akt pathway, leading to the degradation of HIF-1alpha. An in vivo antitumor study demonstrated that AC1-004 reduced tumor size significantly (i.e., by 58.6%), without severe side effects. These results suggest the benzimidazole analogue AC1-004 is a novel HIF inhibitor that targets HIF-1alpha via the Hsp90-Akt pathway, and that it can be used as a new lead in developing anticancer drugs.
AuthorsMi-Sun Won, Namhui Im, Soohyun Park, Shanthaveerappa K Boovanahalli, Yinglan Jin, Xuejun Jin, Kyung-Sook Chung, Moorim Kang, Kiho Lee, Song-Kyu Park, Hwan Mook Kim, Byoung Mog Kwon, Jung Joon Lee, Kyeong Lee
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 385 Issue 1 Pg. 16-21 (Jul 17 2009) ISSN: 1090-2104 [Electronic] United States
PMID19433063 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AC1 004
  • Antineoplastic Agents
  • Benzimidazoles
  • HSP90 Heat-Shock Proteins
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Proto-Oncogene Proteins c-akt
  • Adamantane
Topics
  • Adamantane (analogs & derivatives, chemistry, pharmacology)
  • Antineoplastic Agents (chemistry, pharmacology)
  • Benzimidazoles (chemistry, pharmacology)
  • Cell Line, Tumor
  • Drug Design
  • HSP90 Heat-Shock Proteins (metabolism)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (antagonists & inhibitors)
  • Proto-Oncogene Proteins c-akt (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: